NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-148-2012-0-PCT-02 TOCOPHEROL AND TOCOPHERYL QUINONE DERIVATIVES AS CORRECTORS OF LYSOSOMAL STORAGE DISORDERS PCT PCT PCT/US2013/070156 Expired
NCATS E-148-2012-0-CN-11 TOCOPHEROL AND TOCOPHERYL QUINONE DERIVATIVES AS CORRECTORS OF LYSOSOMAL STORAGE DISORDERS CN DIV 201710324887.3 Pending
NIAMS E-073-2011-1-MX-08 Blockade of TL1A-DR3 Interactions to Ameliorate T Cell Mediated Disease Pathology MX National Stage MX/a/2013/013329 Abandoned
NHLBI E-516-2013-0-US-01 DETECTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK AND MYOCARDIAL INFARCTION RISK US 61/904,408 Abandoned
NHLBI E-515-2013-0-US-01 DETECTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK AND HEART FAILURE RISKd US 61/904,410 Abandoned
NCATS E-148-2012-0-AU-03 TOCOPHEROL AND TOCOPHERYL QUINONE DERIVATIVES AS CORRECTORS OF LYSOSOMAL STORAGE DISORDERS AU National Stage 2013344651 Abandoned
NIA E-103-2011-2-US-02 USE OF ZSCAN4 AND ZSCAN4-DEPENDENT GENES FOR DIRECT REPROGRAMMING OF SOMATIC CELLS US National Stage 14/117,589 9932560 Issued PDF
NCI E-201-2012-0-EP-07 Methods of Treating Patients Infected with HIV and HTLV EP National Stage 13802766.9 Abandoned
NCI E-201-2012-0-PCT-02 Methods of Treating Patients Infected with HIV and HTLV PCT PCT PCT/US2013/069796 Expired
NCI E-201-2012-0-CA-05 Methods of Treating Patients Infected with HIV and HTLV CA National Stage 2891294 Abandoned
NCI E-201-2012-0-AU-04 Methods of Treating Patients Infected with HIV and HTLV AU National Stage 2013344970 Abandoned
NIAAA E-282-2012-0-CA-04 CANNABINOID RECEPTOR MEDIATING COMPOUNDS CA National Stage 2889697 Issued
NIAAA E-282-2012-0-EP-05 CANNABINOID RECEPTOR MEDIATING COMPOUNDS EP National Stage 13802153.0 Issued
NIAAA E-282-2012-0-CH-12 CANNABINOID RECEPTOR MEDIATING COMPOUNDS CH EP 13802153.0 Issued
NIAAA E-282-2012-0-GB-15 CANNABINOID RECEPTOR MEDIATING COMPOUNDS GB EP 13802153.0 Issued
NIAAA E-282-2012-0-IE-16 CANNABINOID RECEPTOR MEDIATING COMPOUNDS IE EP 13802153.0 Issued
NIAAA E-282-2012-0-DE-13 CANNABINOID RECEPTOR MEDIATING COMPOUNDS DE EP 13802153.0 Issued
NIAAA E-282-2012-0-FR-14 CANNABINOID RECEPTOR MEDIATING COMPOUNDS FR EP 13802153.0 Issued
NIAAA E-282-2012-0-IN-06 CANNABINOID RECEPTOR MEDIATING COMPOUNDS IN National Stage 3733/DELNP/2015 Issued
NIAAA E-282-2012-0-CN-08 CANNABINOID RECEPTOR MEDIATING COMPOUNDS CN National Stage 201380069389.9 Issued
NIAAA E-282-2012-0-JP-07 CANNABINOID RECEPTOR MEDIATING COMPOUNDS JP National Stage 2015-542015 Issued
NIAAA E-282-2012-0-PCT-02 CANNABINOID RECEPTOR MEDIATING COMPOUNDS PCT PCT PCT/US2013/069686 Expired
CC E-173-2011-0-US-04 SYSTEM AND METHOD FOR PROBABILISTIC ABLATION PLANNING US National Stage 13/885,714 10423757 Issued PDF
NIAID E-242-2011-0-US-05 Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Crystal Structures and Deep Sequencing US National Stage 14/116,710 10273291 Issued PDF
NCI E-316-2008-0-US-03 Methods And Systems Using Therapeutic, Diagnostic, or Prophylactic Magnetic Agents US CON 14/075,408 9108035 Abandoned PDF
NCI E-081-2011-0-US-03 Tropolone Compounds for Treating or Preventing Retroviral Infection US National Stage 14/116,423 8993768 Issued PDF
NICHD E-157-2011-0-DK-08 Small Molecule Therapeutic Compounds Targeting Thioesterase Deficiency Disorders and Methods of Using the Same DK EP 12716889.6 Issued
NICHD E-157-2011-0-SE-11 Small Molecule Therapeutic Compounds Targeting Thioesterase Deficiency Disorders and Methods of Using the Same SE EP 12716889.6 Issued
NICHD E-157-2011-0-DE-07 Small Molecule Therapeutic Compounds Targeting Thioesterase Deficiency Disorders and Methods of Using the Same DE EP 12716889.6 Issued
NICHD E-157-2011-0-FI-09 Small Molecule Therapeutic Compounds Targeting Thioesterase Deficiency Disorders and Methods of Using the Same FI EP 12716889.6 Issued
NICHD E-157-2011-0-GB-10 Small Molecule Therapeutic Compounds Targeting Thioesterase Deficiency Disorders and Methods of Using the Same GB EP 12716889.6 Issued
NIAID E-145-2011-0-US-08 Plasmodial Surface Anion Channel Inhibitors for the Treatment or Prevention of Malaria US National Stage 14/111,256 9320786 Issued PDF
NCI E-117-2011-0-IT-39 Recombinant Immunotoxin Targeting Mesothelin IT EP 12722586.0 Issued
NCI E-117-2011-0-GB-38 Recombinant Immunotoxin Targeting Mesothelin GB EP 12722586.0 Issued
NCI E-117-2011-0-DE-35 Recombinant Immunotoxin Targeting Mesothelin DE EP 12722586.0 Issued
NCI E-117-2011-0-FR-37 Recombinant Immunotoxin Targeting Mesothelin FR EP 12722586.0 Issued
NCI E-117-2011-0-ES-36 Recombinant Immunotoxin Targeting Mesothelin ES EP 12722586.0 Issued
NCI E-117-2011-0-PE-30 Recombinant Immunotoxin Targeting Mesothelin PE National Stage 2456-11-09 Abandoned
NIAID E-214-2015-0-JP-07 Conformationally Specific Viral Immunogens JP National Stage 2015511675 Pending
NCI E-750-2013-0-US-01 Methods for Selecting and Treating Lymphoma Types US 61/900,553 Abandoned
NCI E-007-2014-0-US-01 ALK1 ANTIBODIES, CONJUGATES THEREOF, AND THEIR USE US 61/900,806 Abandoned
NCI E-117-2011-0-EG-08 Recombinant Immunotoxin Targeting Mesothelin EG National Stage PCT/NA/1697/2013 Abandoned
NIAAA E-258-2012-0-EP-03 Ketone Bodies To Protect Tissues From Damage By Ionizing Radiation EP National Stage 13792209.2 Issued
NIAAA E-258-2012-0-AU-04 Ketone Bodies To Protect Tissues From Damage By Ionizing Radiation AU National Stage 2013337308 Issued
NCI E-117-2011-0-RU-16 Recombinant Immunotoxin Targeting Mesothelin RU National Stage 2013148919 Issued
NCI E-117-2011-0-NZ-14 Recombinant Immunotoxin Targeting Mesothelin NZ National Stage 617386 Abandoned
NIAAA E-258-2012-0-PCT-02 Ketone Bodies To Protect Tissues From Damage By Ionizing Radiation PCT PCT PCT/US2013/068545 Expired
NIAAA E-258-2012-0-JP-06 Ketone Bodies To Protect Tissues From Damage By Ionizing Radiation JP National Stage 2015-541856 Pending
NIAAA E-258-2012-0-CA-05 Ketone Bodies To Protect Tissues From Damage By Ionizing Radiation CA National Stage 2922223 Abandoned
NIAID E-189-2008-2-US-06 LEISHMANIA VACCINE USING SAND FLY SALIVARY IMMUNOGEN US CON 14/069,406 9228002 Issued PDF